Skip to main content

Table 2 Panel of cell lines that were used in the present study

From: Validation of suitable endogenous control genes for quantitative PCR analysis of microRNA gene expression in a rat model of endometrial cancer

Tumour

Genetic background

Pathology

NUT6

(BDIIxBN)xBDII

EAC

NUT43

(BDIIxBN)xBDII

EAC

NUT50

(BDIIxBN)xBDII

EAC

NUT81

(BDIIxBN)xBDII

EAC

NUT128

(BDIIxBN)xBDII

EAC

NUT48

(BDIIxBN)xBDII

NME

NUT75

(BDIIxBN)xBDII

NME

NUT110

(BDIIxBN)xBDII

NME

NUT122

(BDIIxBN)xBDII

NME

NUT129

(BDIIxBN)xBDII

NME

NUT7

(BDIIxSPRD)xBDII

EAC

NUT41

(BDIIxSPRD)xBDII

EAC

NUT42

(BDIIxSPRD)xBDII

EAC

NUT47

(BDIIxSPRD)xBDII

EAC

NUT84

(BDIIxSPRD)xBDII

EAC

NUT58

(BDIIxSPRD)xBDII

NME

NUT68

(BDIIxSPRD)xBDII

NME

NUT74

(BDIIxSPRD)xBDII

NME

NUT89

(BDIIxSPRD)xBDII

NME

NUT91

(BDIIxSPRD)xBDII

NME

  1. The tumour material was derived from cross between females from the EAC-susceptible BDII strain and males from BN or SPRD, respectively. NUT- tumour developed in the backcross (N1) progeny.